1,2-distearoylphosphatidylethanolamine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ankenbruck, N; Cai, X; Chang, EB; Chen, M; Fung, J; Huang, J; Lin, Y; Missiakas, D; Nguyen, M; Penaloza-MacMaster, P; Prominski, A; Randall, G; Rosenberg, J; Shi, J; Tian, B; Tomatsidou, A | 1 |
1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antigen-Antibody Reactions; COVID-19; Drug Evaluation, Preclinical; Hot Temperature; Humans; Immunoconjugates; Light; Mice; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Polymers; Receptors, Virus; SARS-CoV-2; Semiconductors; Spike Glycoprotein, Coronavirus; Thiadiazoles; Virus Inactivation | 2022 |